| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | CVSI Cv Sciences, Inc. | Mona Michael Joseph Jr | 10% Owner | Sell | 500,200 | $0.59 | $295,950.00 | -7.0% | |
| Dec 1, 2020 | BSPK Bespoke Extracts, Inc. | Pollack Danil | CEO | Buy | 20,000,000 | $0.01 | $200,000.00 | +20.2% | |
| Dec 1, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $17.87 | $8,935.55 | -0.7% | |
| Dec 1, 2020 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 1,180 | $161.64 | $190,735.20 | -6.7% | |
| Dec 1, 2020 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 1,645 | $94.66 | $155,720.96 | -12.5% | |
| Dec 1, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 43,000 | $0.25 | $10,766.00 | - | |
| Nov 30, 2020 | AMRN Amarin Corp Plc\uk | Stack David M67 | Director | Buy | 25,000 | $4.86 | $121,517.50 | New | |
| Nov 30, 2020 | LQDA Liquidia Corp | Eshelman Ventures, LLC | 10% Owner | Sell | 400 | $3.13 | $1,252.00 | - | |
| Nov 27, 2020 | BHC Bausch Health Companies Inc. | Humphries William D. | President, Ortho-dermatologics | Sell | 36,804 | $19.63 | $722,519.22 | -5.0% | |
| Nov 25, 2020 | BMY Bristol Myers Squibb Co | Von Autenried Paul | EVP, Chief Information Officer | Sell | 3 | $63.50 | $190.50 | - | |
| Nov 25, 2020 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 10,500 | $161.51 | $1,695,810.00 | -15.1% | |
| Nov 25, 2020 | LQDA Liquidia Corp | Eshelman Ventures, LLC | 10% Owner | Sell | 464,175 | $3.17 | $1,470,443.05 | -1.7% | |
| Nov 24, 2020 | BMY Bristol Myers Squibb Co | Dubow Adam63 | SVP,Chiefcompliance&Ethicsoff. | Sell | 900 | $63.39 | $57,051.00 | -5.6% | |
| Nov 24, 2020 | BMY Bristol Myers Squibb Co | Von Autenried Paul | EVP, Chief Information Officer | Sell | 20,000 | $62.75 | $1,255,000.00 | -13.6% | |
| Nov 24, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 17,827 | $0.23 | $4,145.02 | - | |
| Nov 24, 2020 | ORGO Organogenesis Holdings Inc. | Avista Capital Managing Member Iv, LLC | Director, 10% Owner | Buy | 2,839 | $4.99 | $14,170.62 | - | |
| Nov 23, 2020 | BMY Bristol Myers Squibb Co | Vessey Rupert53 | EVP, Research &Early Dev. | Sell | 13,421 | $61.34 | $823,244.14 | -26.1% | |
| Nov 20, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 16,000 | $0.24 | $3,900.00 | - | |
| Nov 19, 2020 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 6,000 | $164.06 | $984,360.00 | -14.4% | |
| Nov 19, 2020 | BMY Bristol Myers Squibb Co | Vessey Rupert53 | EVP, Research &Early Dev. | Sell | 57,591 | $61.30 | $3,530,269.47 | -37.1% | |
| Nov 19, 2020 | ORGO Organogenesis Holdings Inc. | Avista Capital Managing Member Iv, LLC | Director, 10% Owner | Buy | 4,404,162 | $3.29 | $14,500,671.64 | +3.8% | |
| Nov 17, 2020 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Sell | 100,000 | $7.33 | $733,400.00 | -1.8% | |
| Nov 17, 2020 | ORGO Organogenesis Holdings Inc. | Ades Alan A. | Director, 10% Owner | Buy | 833,153 | $3.25 | $2,707,747.25 | +0.6% | |
| Nov 17, 2020 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 20,829 | $3.25 | $67,694.25 | +153.1% | |
| Nov 17, 2020 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H75 | Director, 10% Owner | Buy | 833,153 | $3.25 | $2,707,747.25 | +0.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.